Zimmer Alexandra S相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Consortium for Intracranial Metastasis Academic Research (CIMARa): Global interdisciplinary collaborations to improve outcomes of patient with brain metastases

颅内转移瘤学术研究联盟（CIMARa）：全球跨学科合作，旨在改善脑转移瘤患者的治疗效果

期刊:NeuroOncology Advances

影响因子:4.1

doi:10.1093/noajnl/vdaf049

Anders, Carey K; Van Swearingen, Amanda E D; Neman, Josh; Joyce, Johanna A; Cittelly, Diana M; Valiente, Manuel; Zimmer, Alexandra S; Floyd, Scott R; Dhakal, Ajay; Sengupta, Soma; Ahluwalia, Manmeet S; Nagpal, Seema; Kumthekar, Priya U; Emerson, Sam; Basho, Reva; Beal, Kathryn; Moss, Nelson S; Razis, Evangelia D; Yang, Jonathan T; Sammons, Sarah L; Sahebjam, Solmaz; Tawbi, Hussein A

发表日期：2025

文献求助收藏

A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models.

CSF-1R 抑制剂在血液传播的临床前模型中既能预防又能治疗三阴性乳腺癌脑转移

期刊:Clinical & Experimental Metastasis

影响因子:3.2

doi:10.1007/s10585-025-10366-x

Zhang Wei, Rahman Samiur, Wu Alex M L, Isanogle Kristine, Robinson Christina, Kumar Dinesh, Khan Imran, Wei Debbie, Zimmer Alexandra S, Fujii Takeo, Difilippantonio Simone, Lipkowitz Stanley, Steeg Patricia

发表日期：2025

文献求助收藏

Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

T-DM1 和节拍式替莫唑胺用于 HER2 阳性乳腺癌脑转移二级预防的 I 期研究和无细胞 DNA 分析

期刊:Clinical Cancer Research

影响因子:10.2

doi:10.1158/1078-0432.CCR-22-0855

Jenkins, Sarah; Zhang, Wei; Steinberg, Seth M; Nousome, Darryl; Houston, Nicole; Wu, Xiaolin; Armstrong, Terri S; Burton, Eric; Smart, Dee Dee; Shah, Ritu; Peer, Cody J; Mozarsky, Brett; Arisa, Oluwatobi; Figg, William D; Mendoza, Tito R; Vera, Elizabeth; Brastianos, Priscilla; Carter, Scott; Gilbert, Mark R; Anders, Carey K; Connolly, Roisín M; Tweed, Carol; Smith, Karen L; Khan, Imran; Lipkowitz, Stanley; Steeg, Patricia S; Zimmer, Alexandra S

细胞生物学

发表日期：2023

文献求助收藏

A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

ONC201治疗复发/难治性转移性乳腺癌和晚期子宫内膜癌的单臂、开放标签II期研究

期刊:Oncologist

影响因子:4.2

doi:10.1093/oncolo/oyad164

Atkins, Sarah L P; Greer, Yoshimi Endo; Jenkins, Sarah; Gatti-Mays, Margaret E; Houston, Nicole; Lee, Sunmin; Lee, Min-Jung; Rastogi, Shraddha; Sato, Nahoko; Burks, Christina; Annunziata, Christina M; Lee, Jung-Min; Nagashima, Kunio; Trepel, Jane B; Lipkowitz, Stanley; Zimmer, Alexandra S

子宫内膜癌

发表日期：2023

文献求助收藏

HER2-positive breast cancer brain metastasis: A new and exciting landscape

HER2阳性乳腺癌脑转移：一个崭新而令人兴奋的领域

期刊:Cancer Reports

影响因子:1.9

doi:10.1002/cnr2.1274

Zimmer, Alexandra S; Van Swearingen, Amanda E D; Anders, Carey K

发表日期：2022

文献求助收藏

"Triple-Negative Breast Cancer Central Nervous System Metastases From the Laboratory to the Clinic"

“三阴性乳腺癌中枢神经系统转移：从实验室到临床”

期刊:Cancer Journal

影响因子:2.2

doi:10.1097/PPO.0000000000000503

Zimmer, Alexandra S

发表日期：2021

文献求助收藏

HER2 antibody-drug conjugate controls growth of breast cancer brain metastases in hematogenous xenograft models, with heterogeneous blood-tumor barrier penetration unlinked to a passive marker

HER2抗体药物偶联物在血源性异种移植模型中控制乳腺癌脑转移瘤的生长，其血脑屏障穿透的异质性与被动标志物无关。

期刊:Neuro-Oncology

影响因子:13.4

doi:10.1093/neuonc/noaa118

Gril, Brunilde; Wei, Debbie; Zimmer, Alexandra S; Robinson, Christina; Khan, Imran; Difilippantonio, Simone; Overstreet, Michael G; Steeg, Patricia S

发表日期：2020

文献求助收藏

Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases

替莫唑胺在HER2阳性乳腺癌脑转移二级预防中的应用

期刊:Future Oncology

影响因子:2.6

doi:10.2217/fon-2020-0094

Zimmer, Alexandra S; Steinberg, Seth M; Smart, Dee Dee; Gilbert, Mark R; Armstrong, Terri S; Burton, Eric; Houston, Nicole; Biassou, Nadia; Gril, Brunilde; Brastianos, Priscilla K; Carter, Scott; Lyden, David; Lipkowitz, Stanley; Steeg, Patricia S

发表日期：2020

文献求助收藏

A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses

一项针对复发性女性癌症的 I 期研究，评估了 PD-L1 抑制剂度伐利尤单抗联合 PARP 抑制剂奥拉帕尼和 VEGFR1-3 抑制剂西地尼布的疗效，并进行了生物标志物分析。

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1186/s40425-019-0680-3

Zimmer, Alexandra S; Nichols, Erin; Cimino-Mathews, Ashley; Peer, Cody; Cao, Liang; Lee, Min-Jung; Kohn, Elise C; Annunziata, Christina M; Lipkowitz, Stanley; Trepel, Jane B; Sharma, Rajni; Mikkilineni, Lekha; Gatti-Mays, Margaret; Figg, William D; Houston, Nicole D; Lee, Jung-Min

发表日期：2019

文献求助收藏

Pilot study to assess visualization and therapy of inflammatory mechanisms after vessel reopening in a mouse stroke model

一项旨在评估小鼠中风模型中血管重新开放后炎症机制的可视化和治疗的初步研究

期刊:Scientific Reports

影响因子:3.8

doi:10.1038/s41598-017-17533-5

Ebba Beller, Laura Reuter, Anne Kluge, Christine Preibisch, Ute Lindauer, Alexei Bogdanov, Friederike Lämmer, Claire Delbridge, Kaspar Matiasek, Benedikt J Schwaiger, Tobias Boeckh-Behrens, Claus Zimmer, Alexandra S Gersing

发表日期：2018

文献求助收藏